Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Fuji
Covington
Healthtrust
US Department of Justice
Colorcon
Moodys
Express Scripts

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065292

« Back to Dashboard

NDA 065292 describes CEFOTAXIME SODIUM, which is a drug marketed by Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, Lupin, and Wockhardt, and is included in nine NDAs. It is available from two suppliers. Additional details are available on the CEFOTAXIME SODIUM profile page.

The generic ingredient in CEFOTAXIME SODIUM is cefotaxime sodium. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for 065292
Tradename:CEFOTAXIME SODIUM
Applicant:Hospira Inc
Ingredient:cefotaxime sodium
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 065292

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10GM BASE/VIAL
Approval Date:Aug 10, 2006TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Harvard Business School
Moodys
Julphar
UBS
Covington
US Army
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.